Session 22 - MedTech

 Registration is closed for this event
campus EPFL salle BC 410, Lausanne

Lieu et date

Présentations

  • Labseed, Hicham Majd
    Labseed invented the first solution which completely suppresses the formation of fibrous tissue around all kinds of implantable devices: MYcoat.
  • Motilis, Richard Andrews
    Motilis is specialized in gastroenterology that supplies ingestible pills to both the research and clinical markets.
  • Chimeric LifeSciences, Dennis Church
    Design and development of antiinflammatory and cancer drugs using lymphoid and myeloid tissue-selective drug transporters.

Programme

  • dès 19h00: Accueil et Networking
  • 19h30:       Présentations
  • 20h00:       Repas buffet

Membres invités

  • membres A3 Angels
  • membres A3 intéressé à devenir mentor ou investisseurs
  • Entrepreneurs hautes technologies

Inscription

  • Inscription :  jusqu'au lundi 7 Mars 2011 à 18h00.
  • Cout : 50CHF, sur place mais inscription obligatoire.
March 9th, 2011 19:00   through   22:30
membre / non-membres CHF 50.00